- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- July 2023
- 129 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- April 2024
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- November 2023
- 185 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- November 2023
- 178 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 180 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 170 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- March 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- October 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,617GBP
- Report
- January 2024
- 140 Pages
Global
From €4109EUR$4,250USD£3,531GBP
- Report
- November 2023
- 161 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- November 2023
- 147 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- June 2023
- 149 Pages
Global
From €2417EUR$2,500USD£2,077GBP
The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more